Novartis Sues MSN Pharmaceuticals Over ‘Novadoz’ Trademark

Novartis Pharmaceuticals Corp. accused generics-maker MSN Pharmaceuticals Inc. of planning a “scheme designed to confuse consumers” over the source of its “Novadoz” version of the blockbuster heart medication Entresto.

Novartis—already fighting a patent battle over the generic—alleged MSN plans to distribute its generic under its Novadoz brand, according to a US District Court for the District of New Jersey complaint. It said that name blends “Novartis” and “Sandoz,” the name of Novartis’ own generics-making subsidiary.

MSN also will infringe Novartis’ trade dress by copying the sizes, shape and colors of the three-tablet Ernesto regimen as well as blue and ...